Henrike Heyne

@hheyne.bsky.social

Research group leader at Hasso Plattner Institute. Medical genomics, precision medicine, epilepsy.

In a new study, @hheyne.bsky.social and her team identified a Finnish-enriched missense variant in the SCN5A gene that acts like a natural lifelong cardiac sodium channel blockade, decreasing the risk of cardiac arrhythmias while also having some negative effects. hpi.de/en/article/h...

HPI study finds advances in the treatment of heart disease

HPI researchers Dr. Henrike Heyne, Julian Wanner and their team discover gene variant that acts like heart medication. Their study has now been published.

hpi.de